Fortrea Holdings (FTRE) Long-Term Deferred Tax (2022 - 2026)
Fortrea Holdings' (FTRE) quarterly Long-Term Deferred Tax came in at $6.2 million in Q2 2026, up 10.71% on a YoY basis from $5.6 million in Q2 2025, and little changed quarter-over-quarter from $6.2 million in Q1 2026.
Analysis
Fortrea Holdings (FTRE) Long-Term Deferred Tax (2022 - 2026) Analysis & Trends
Fortrea Holdings (FTRE) has reported Long-Term Deferred Tax for 5 consecutive years, with $6.2 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Long-Term Deferred Tax rose 10.71% year-over-year to $6.2 million; the trailing twelve-month figure through Jun 2026 stood at $6.2 million (up 10.71% YoY), and the FY2025 full-year result was $6.2 million, up 19.23% from the prior year.
- Long-Term Deferred Tax held at $6.2 million in Q2 2026 per FTRE's latest filing, from $6.2 million in the prior quarter.
- Across five years, Long-Term Deferred Tax topped out at $8.3 million in Q3 2025 and bottomed at $1.2 million in Q4 2022.
- Historically, Long-Term Deferred Tax has averaged $4.3 million across 5 years, with a median of $4.2 million in 2023.
- The sharpest annual moves came in 2023 and 2026: Long-Term Deferred Tax soared 166.67% in 2023, then rose 10.71% in 2026.
- Over 5 years, Long-Term Deferred Tax stood at $1.2 million in 2022, then jumped by 166.67% to $3.2 million in 2023, then soared by 62.5% to $5.2 million in 2024, then rose by 19.23% to $6.2 million in 2025, then changed by 0.0% to $6.2 million in 2026.
- According to Business Quant data, Long-Term Deferred Tax over the past three periods registered $6.2 million, $6.2 million, and $6.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.06 Bn | 42.11 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn |
| 3 | Charles River Laboratories International | 13.77 Bn | 13.62 Bn | 452.07 Mn |
| 4 | Icon | 12.62 Bn | 11.69 Bn | 479.29 Mn |
| 5 | Fortrea Holdings | 1.68 Bn | 1.51 Bn | 139.20 Mn |
| 6 | Evotec SE | 661.34 Mn | 235.46 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 442.79 Mn | 358.26 Mn | 18.44 Mn |
| 8 | Champions Oncology | 72.49 Mn | 72.62 Mn | 7.03 Mn |
| 9 | MindWalk Holdings | 61.66 Mn | 53.38 Mn | 1.82 Mn |
| 10 | VivoSim Labs | 1.47 Mn | 1.47 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.20 Mn |
| Mar 31, 2026 | 6.20 Mn |
| Dec 31, 2025 | 6.20 Mn |
| Sep 30, 2025 | 8.30 Mn |
| Jun 30, 2025 | 5.60 Mn |
| Mar 31, 2025 | 5.40 Mn |
| Dec 31, 2024 | 5.20 Mn |
| Sep 30, 2024 | 3.20 Mn |
| Jun 30, 2024 | 3.20 Mn |
| Mar 31, 2024 | 3.20 Mn |
| Dec 31, 2023 | 3.20 Mn |
| Sep 30, 2023 | 1.60 Mn |
| Jun 30, 2023 | 2.00 Mn |
| Dec 31, 2022 | 1.20 Mn |